Hoche Avocats advises the historic majority shareholders, as well as the management, on the LBO ter of BCF LIFE SCIENCES.

Hoche Avocats advises the historic majority shareholders, as well as the management, on the LBO ter of BCF LIFE SCIENCES.

Based in Pleucadeuc in Morbihan, BCF life Sciences company is a leader in free amino acids retrieval, and realizes a turnover of approximately 30M€ in 2017, of which more than 60% internationally.

Since the takeover in 2012 by Cerea Capital, supported by Sodero Gestion, and with the help of the Managers, the Group’s economic performances has significantly progress.

BCF Life Sciences intends to keep on developing its growth and enhance its industrial knowledge and its products.

Thus, BCF Life Sciences reorganizes its capital and signs an LBO ter with MBO Partenaires. MBO Partenaires’ investment will give the Management, which reinvests significantly in the transaction to reinforce its majority, the financial resources, and the emotional support needed for the further development of the Group.

Hoche Avocats was the historic majority shareholders and the management’s counsel with a team composed by Grine Lareche (associate), Christophe Bornes (counsel) and Alexia Angileri (lawyer) for the legal aspects.
Other contributors: De Pardieu Brocas Maffei, Goodwin Procter LLP.